Atypical Antipsychotics as First-Line Treatments for Schizophrenia: Advantages for Stakeholders in the UK Healthcare System

Author: Mortimer A.M.  

Publisher: Adis International

ISSN: 1173-8790

Source: Disease Management & Health Outcomes, Vol.12, Iss.3, 2004-01, pp. : 169-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract